How Deplin Compares to Folic Acid

Deplin compares to folic acid (chart)

Why Folic Acid cannot be substituted for Deplin®

Prevalence of C->T Polymorphism in General Population1
(chart)

Prevalence of T/T Polymorphism in depressed patients5
(chart)

  1. Popakostas, J. Clinical Psychiatry; 2004, 1090-1095
  2. Bottiglieri T, Prog in Neuro-Psychopharm & Bio Psych, 2005
  3. Bjelland, I., et. al; . Arch. Gen. Psychiatry 2003, 618-626
  4. Procopciuc L.M., Presented at Biological Psychiatry, Poster P86
  5. Arinami T, AM J. Medical Genetics 1997
  6. Kelly B., Journal of Psychopharmacology 18(4) (2004) 567-571

Bioavailability

Mean Pharmacokinetic Parameters for L-MTHF after administration of Folic acid or 5-MTHF

Peak Plasma Levels of L-Methylfolate vs. folic acid: The peak concentration of the active natural stereoisomer 6(S) 5-MTHF following the administration of 6(R,S)-5-MTHF was more than seven times higher compared to the peak level of the 6(S) 5-MTHF following the administration of folic acid (Figure 3), irrespective of the patient's MTHFR genotype (Figure 7).17

Genotype and treatment

* Willems, et al, British Jrnl of Pharmacology, 2004

Deplin® is the first medical food product indicated for the distinct nutritional requirements of persons with low plasma and/or low red blood cell folate with particular emphasis for those individuals who have a major depressive disorder that has not fully responded or may not fully respond to antidepressant therapy.